Orotic acid potassium salt
Orotic acid potassium salt structure
|
Common Name | Orotic acid potassium salt | ||
|---|---|---|---|---|
| CAS Number | 24598-73-0 | Molecular Weight | 194.187 | |
| Density | 2.3534 | Boiling Point | N/A | |
| Molecular Formula | C5H3KN2O4 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
Use of Orotic acid potassium saltOrotic acid (potassium salt) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
| Name | potassium,2,4-dioxo-1H-pyrimidine-6-carboxylate |
|---|---|
| Synonym | More Synonyms |
| Description | Orotic acid (potassium salt) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| Density | 2.3534 |
|---|---|
| Molecular Formula | C5H3KN2O4 |
| Molecular Weight | 194.187 |
| Exact Mass | 193.972992 |
| PSA | 105.85000 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | RM3201500 |
| HS Code | 2933599090 |
|
~%
Orotic acid pot... CAS#:24598-73-0 |
| Literature: Journal of the Chemical Society, Dalton Transactions, , # 7 p. 1330 - 1335 |
| Precursor 1 | |
|---|---|
| DownStream 1 | |
CAS#:16492-28-7| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver.
J. Lipid Res. 52 , 1617-1625, (2011) Orotic acid (OA), an intermediate in pyrimidine metabolism, has been used for a variety of purposes, such as dietary supplements. Although it is well documented that OA induces fatty liver in a specie... |
|
|
Molecular, kinetic and thermodynamic characterization of Mycobacterium tuberculosis orotate phosphoribosyltransferase.
Mol. Biosyst. 8(2) , 572-86, (2011) Tuberculosis (TB) is a chronic infectious disease caused mainly by Mycobacterium tuberculosis. The worldwide emergence of drug-resistant strains, the increasing number of infected patients among immun... |
|
|
Production of uridine 5'-monophosphate by Corynebacterium ammoniagenes ATCC 6872 using a statistically improved biocatalytic process.
Appl. Microbiol. Biotechnol. 76 , 321-328, (2007) Attempts were made with success to develop a two-step biocatalytic process for uridine 5'-monophosphate (UMP) production from orotic acid by Corynebacterium ammoniagenes ATCC 6872: the strain was firs... |
| Potassium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate |
| Dioron |
| potassium 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate |
| potassium oroate |
| 6-Carboxy-2,4-dihydroxypyrimidine Uracil-6-carboxylic acid |
| 2,6-dioxo-1,2,3,6-tetrahydro-pyrimidine-4-carboxylic acid,potassium-salt |
| Orotic acid,monopotassium salt |
| 4-Pyrimidinecarboxylic acid,1,2,3,6-tetrahydro-2,6-dioxo-,monopotassium salt |
| Potassium 2,6-dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylate |
| MFCD00039118 |
| EINECS 246-341-0 |
| orotic acid potassium salt |
| Ba 2658 |
| Potassium orotate |
| 4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, potassium salt (1:1) |
| potassium hydroorotate |
| 2,6-Dioxo-1,2,3,6-tetrahydro-pyrimidin-4-carbonsaeure,Kalium-Salz |